Urinary Catecholamines: Nursing Guide
Urinary catecholamines measure epinephrine, norepinephrine, and dopamine excreted over 24 hours — most useful when spells of hypertension, palpitations, and sweating suggest a catecholamine-secreting tumor. the reporting laboratory emphasizes this is not a first-line pheochromocytoma screen; fractionated plasma or urine metanephrines usually come first. Nurses protect validity with acid preservative before the first void, complete timed collection, medicine review, and refrigerated storage — then pair results with symptoms rather than treating one fraction as a final diagnosis.
Contents
Quick Facts
Key Takeaway
Urinary catecholamines are an auxiliary test — collection during a spell, complete 24-hour volume with preservative, and medicine holds matter as much as the reported fraction values.
Specimen & Collection Details
Nurse quick-reference for collection prep that affects result quality.
Laboratory 24-hour urine container with preservative
the reporting laboratory: add 25 mL of 50% acetic acid at collection start (15 mL for children younger than 5 years) — or boric acid or other laboratory-approved preservative per local protocol; preservative must be in the container before the first void
24-hour urine (acid-preserved container per laboratory)
Complete 24-hour urine volume required — report total volume in milliliters; minimum aliquot approximately 2 mL per the reporting laboratory
24-hour timed collection; Mayo guidance greatest value when collected during a hypertensive episode or catecholamine spell — document start and stop clock times and whether symptoms occurred during the collection window
No universal fasting requirement is specified in reviewed references; avoid caffeine, nicotine, and strenuous exercise before and during collection when laboratory protocol requires — follow ordering clinician and laboratory patient-preparation instructions
Keep container refrigerated throughout the 24-hour period per the reporting laboratory and institutional policy; transport to laboratory within stability limits
Commonly several days when performed at a reference laboratory — varies by institution
Endocrine or specialty chemistry laboratory — often send-out (LC-MS/MS)
What is Urinary Catecholamines?
Urinary Catecholamines measures fractionated epinephrine, norepinephrine, and dopamine in a 24-hour urine specimen. Catecholamines are neurotransmitters and hormones derived from tyrosine; systemic circulating fractions come mainly from the adrenal medulla with smaller sympathetic contribution. In catecholamine-secreting tumors such as pheochromocytoma, paraganglioma, and some neuroblastoma-related tumors, urine levels of one or more fractions may rise, often with episodic or sustained hypertension and spell symptoms. the reporting laboratory lists this as an auxiliary test — not first-line for pheochromocytoma — when fractionated metanephrine testing leaves diagnostic uncertainty.
Overview
Nurses coordinate urinary catecholamines when endocrine or oncology teams investigate episodic hypertension with palpitations, headache, sweating, tremor, or nausea suggesting catecholamine excess. the reporting laboratory recommends fractionated plasma or 24-hour urine metanephrines as first-line pheochromocytoma screening — urinary catecholamines may follow when those results are indeterminate or as part of neuroblastoma-related follow-up alongside vanillylmandelic acid and homovanillic acid testing per specialist plan.
Pre-analytic integrity dominates nursing work: add preservative before the first void, include every urine portion for exactly 24 hours, record total volume, refrigerate the container, and document interfering medicines. Mayo patient preparation advises withdrawing drugs that release or block catecholamine metabolism for at least one week when medically feasible, and stopping exogenous epinephrine, norepinephrine, or dopamine infusions for at least 12 hours unless monitoring those drugs. Caffeine, nicotine, stress, and tyramine-rich foods can transiently raise values — teach patients what to avoid per laboratory list. Escalate hemodynamic instability, chest pain, or neurologic symptoms during spells according to facility policy — do not defer urgent care for pending urine results alone.
Before starting the 24-hour collection, confirm preservative is in the container, verify medicine hold instructions with the prescriber, teach complete void capture and refrigeration, and document whether the patient is having active spell symptoms. After the specimen ships, review fractions with blood pressure trends and first-line metanephrine results — not as a stand-alone tumor diagnosis.
Spell Symptoms, Preservative, and Urinary Catecholamine Safety
Urinary catecholamines are easily invalidated before the laboratory opens the container. Missing acid preservative, a partial 24-hour collection, or continued caffeine and interfering medicines can produce false leads — while hypertensive spells during collection still require urgent clinical action independent of pending fractions.
- Hypertensive emergency or unstable spell with chest pain or neurologic symptoms — escalate per facility policy
- Preservative not added before the first void — specimen may be rejected; notify laboratory and prescriber
- Using urinary catecholamines as first-line pheochromocytoma screening when metanephrines were not obtained per Mayo guidance
- Surgery or alpha-blockade decisions based on an incomplete collection or unknown total volume
Document: preservative verification, 24-hour start/stop times, total volume, spell symptoms with vitals, medicine holds, refrigeration, and prescriber or laboratory notifications.
What Urinary Catecholamines Can and Cannot Tell You
This test can help identify:
- Elevated urine epinephrine, norepinephrine, or dopamine fractions when collection and medicine conditions are valid
- Auxiliary biochemical support when fractionated metanephrines are indeterminate in spell-suggestive patients
- Need for specialist imaging, genetics, or repeat timed collection when fractions and symptoms align
- Pre-analytic problems (missing preservative, incomplete voids) before irreversible treatment paths
This test cannot:
- Serve as the first-line pheochromocytoma screen — metanephrines are preferred per the reporting laboratory
- Localize adrenal versus extra-adrenal tumor or determine malignancy without imaging and specialist review
- Replace hemodynamic assessment during hypertensive spells
- Be interpreted when preservative, volume, or medicine hold requirements were not met
Pre-collection Checks for 24-Hour Urinary Catecholamines
Verify
Clarify before proceeding when:
- First-line metanephrine testing was never performed but pheochromocytoma is the question — clarify order sequence with prescriber
- Patient is withdrawing from alcohol, benzodiazepines, clonidine, or opioids — Mayo cautions against testing during rebound catecholamine release unless laboratory agrees
- Preservative was forgotten or added after the first void
- Patient cannot refrigerate urine and no cooler plan exists
- Active hypertensive spell with neurologic or chest symptoms — treat urgently while coordinating collection
- Prior 24-hour urine was rejected for missing volume documentation
Reading Urine Fractions With Metanephrine and Spell Context
Integrate fractionated results with age-matched reference intervals, total 24-hour volume, spell timing, metanephrine context, and blood pressure trends. Mayo decision levels for pheochromocytoma apply only when pre-analytic conditions are valid.
| Pattern (general) | May suggest | Nursing focus |
|---|---|---|
| Fractions within reference + negative metanephrines + stable symptoms | Pheochromocytoma less likely | Communicate with prescriber; continue spell and hypertension workup as ordered |
| Norepinephrine >80 mcg/24 h or epinephrine >20 mcg/24 h (Mayo sensitivity cutoffs) | Possible catecholamine excess — auxiliary support | Notify prescriber; monitor vitals; prepare for imaging per team |
| Norepinephrine >170 mcg/24 h or epinephrine >35 mcg/24 h (Mayo specificity cutoffs) | Higher specificity for tumor pathway | Urgent prescriber communication per policy; continue spell precautions |
| Invalid collection or unknown volume | Result not interpretable | Notify laboratory and prescriber; plan repeat during symptoms if ordered |
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
Preservative, Caffeine, and Spell Timing at the Bedside
| Bedside point | Nursing note |
|---|---|
| Preservative first | Acid must be in the container before the discarded initial void — not added at hour 12 |
| Spell diary | Ask the patient to note time of palpitations, sweating, and BP if home monitoring during collection |
| Coffee and energy drinks | Common hidden caffeine sources — document exposure even if “only one cup” |
| First-line trap | Do not skip metanephrine discussion — urinary catecholamines are auxiliary per Mayo |
| Volume on label | Total milliliters must travel with the aliquot — missing volume delays or rejects testing |
| Spell vs crisis | Paroxysmal hypertension needs monitoring; emergency features need escalation regardless of pending urine |
Why Urinary Catecholamines is Ordered
Urinary catecholamines are ordered when clinicians need auxiliary catecholamine excretion data beyond first-line metanephrine testing or as part of specialized neuroendocrine tumor follow-up.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Auxiliary pheochromocytoma or paraganglioma evaluation | Do urine catecholamine fractions support catecholamine excess when metanephrine testing is equivocal? | the reporting laboratory states urine catecholamine measurements can assist when plasma or urine metanephrine results do not fully exclude pheochromocytoma — especially if collected during a hypertensive spell. |
| Neuroblastoma and related tumor biochemical follow-up | Are catecholamine fractions elevated alongside other urine markers in pediatric oncology pathways? | Mayo lists auxiliary use with vanillylmandelic acid and homovanillic acid in neuroblastoma-related tumors — interpretation and thresholds are specialist-led. |
| Spell symptoms with episodic autonomic activation | Does timed urine excretion correlate with paroxysmal hypertension, palpitations, or diaphoresis? | Collection during symptomatic spells may increase diagnostic yield per Mayo ordering guidance. |
| Monitoring selected catecholamine-secreting tumors | Are serial urine fractions needed to trend treatment response per oncology or endocrine plan? | Follow-up testing is ordered by specialists; nurses ensure comparable collection conditions between specimens. |
Contraindications and Precautions
There is no absolute contraindication to urine collection, but Mayo cautions against testing patients withdrawing from drugs that cause rebound catecholamine release unless the clinical team and laboratory agree on timing.
- Hypertensive emergency features during a spell — escalate per facility policy while specimen coordination continues
- Preservative not added before first void or collection started without empty-bladder discard — specimen may be rejected; notify laboratory and prescriber before relying on results
- Labeling confirmed pheochromocytoma from one elevated fraction without metanephrine context or imaging per specialist pathway
- Monoamine oxidase inhibitors, cocaine, some anesthetics, clonidine withdrawal, and other listed drugs may alter catecholamine metabolism — document all medicines and follow one-week withdrawal guidance when medically feasible per Mayo cautions
- Caffeine, nicotine, stress, exercise, and tyramine-rich foods (e.g., nuts, cheese, bananas) may transiently increase excretion — follow laboratory avoidance instructions
- Incomplete 24-hour collection, missing volume, or room-temperature storage without refrigeration invalidates interpretation
- Severe hypertension with chest pain, neurologic symptoms, or pulmonary edema during spells
- Sustained tachycardia with hemodynamic instability pending biochemical workup
- Critical laboratory notification or markedly elevated fractions with active spell symptoms — urgent prescriber communication per facility policy
Patient Preparation
Preparation spans medicine review, dietary and lifestyle restrictions, preservative container setup, patient teaching on timed collection, and refrigerated storage.
Pre-test checksthe reporting laboratory advises discontinuing drugs that release or hinder metabolism of epinephrine, norepinephrine, or dopamine for at least one week when medically feasible, and stopping exogenous catecholamine infusions for at least 12 hours when not drug monitoring. Document monoamine oxidase inhibitors, tricyclic antidepressants, cocaine, sympathomimetics, clonidine, beta-blockers, calcium channel blockers, and diuretics — do not stop prescribed medicines without prescriber guidance. Contact the laboratory if withdrawal is not possible.
Performance — nursing procedure guide
This page is a Tests & Diagnostics guide for Urinary Catecholamines. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Step-by-step technique, supplies, infection prevention, and immediate post-procedure monitoring for this test are covered in:
Use the Patient preparation, Results and interpretation, and Nursing responsibilities sections on this page for order verification, pre-analytic checks, result follow-up, critical-value escalation, and documentation.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
Interpret fractionated epinephrine, norepinephrine, and dopamine with age-matched reference intervals, total 24-hour volume, collection quality, spell timing, and first-line metanephrine results. Mayo-derived decision levels for pheochromocytoma workup apply only when pre-analytic conditions are valid.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Within reference interval | Within age- and sex-matched laboratory reference interval for each fraction — Mayo adult ≥10 years examples: norepinephrine approximately 15–80 mcg/24 h; epinephrine approximately 0.5–20 mcg/24 h; dopamine approximately 65–400 mcg/24 h (≥4 years for dopamine pediatric intervals differ) | Fractions within reference interval — pheochromocytoma less likely when first-line metanephrines are also negative and symptoms are stable, per prescriber interpretation | Communicate results to ordering clinician; continue broader hypertension or spell workup as ordered — avoid false reassurance if collection was incomplete |
| Borderline / near reference limit | Mildly elevated fraction near upper reference limit or discordant fractions without spell-timed collection | Equivocal — may need repeat 24-hour collection during symptoms or complementary testing | Notify prescriber; verify collection integrity and medicine interference before major decisions |
| High / above reference interval | Mayo pheochromocytoma decision levels (examples): norepinephrine greater than 80 mcg/24 h with approximately 86% sensitivity; greater than 170 mcg/24 h for higher specificity; epinephrine greater than 20 mcg/24 h (sensitivity) or greater than 35 mcg/24 h (specificity) — use reporting laboratory thresholds | Supports catecholamine excess when interpreted with symptoms and metanephrine context — does not alone localize tumor or replace imaging | Urgent prescriber notification per facility policy; continue hemodynamic monitoring; support endocrine or oncology referral and imaging per team plan |
| Low / below reference interval | Below reference interval for one or more fractions | May reflect autonomic dysfunction, incomplete collection dilution error, or non-tumor causes — clinical correlation required | Review collection volume and timing with laboratory; communicate to prescriber without dismissing ongoing spell symptoms |
Hypertensive Spell and Critical Result Escalation
Universal institution-wide critical-value thresholds for every urine catecholamine fraction are not specified in published references. Urgent nursing action depends on severe symptoms, hemodynamic instability, local critical-result policy, and prescriber notification requirements — not the numeric value alone.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Hypertensive emergency or unstable spell in progress | Severe blood pressure elevation with chest pain, neurologic change, or pulmonary edema | Escalate according to facility policy; parallel nursing care takes priority over pending urine results |
| Markedly elevated fractions with active autonomic spell | Critically high result notification or fractions above specialist threshold with ongoing symptoms | Immediate prescriber communication; monitor vitals and cardiac rhythm per protocol |
| Invalid collection driving treatment decisions | Missing preservative, unknown volume, missed voids, or collection without required medicine holds documented | Notify laboratory and prescriber before surgery or alpha-blockade plans based on that specimen |
Stop routine outpatient collection teaching and escalate according to facility policy when the patient develops hypertensive emergency features, hemodynamic instability, or when an invalid urine specimen would guide irreversible treatment (e.g., preoperative alpha-blockade or urgent surgery) without prescriber and laboratory review.
Factors Affecting Results
Urinary catecholamines are sensitive to collection quality, preservative pH, medicines, diet, stress, age, and renal function uncertainty per Mayo cautions.
- Caffeine, nicotine, acute stress, or exercise shortly before or during collection
- Interfering medicines not withdrawn per protocol (sympathomimetics, MAO inhibitors, cocaine)
- Incomplete collection concentrating analyte or collection outside symptomatic spell window
- Collection during asymptomatic interval in episodic pheochromocytoma
- Continued interfering medicines or active catecholamine infusions
- Specimen degradation from missing acid preservative or inadequate refrigeration
- Medicine exposure and infusion timing
- 24-hour timing, total volume, and preservative type
- Caffeine, nicotine, diet, stress, and spell-symptom correlation
the reporting laboratory states urinary catecholamines should not be used as the first-line test for pheochromocytoma — fractionated metanephrines in plasma or urine are preferred. Sensitivity and specificity of urine catecholamine cutoffs are lower than metanephrine testing. The assay cannot localize tumor, determine malignancy, or replace specialist imaging and genetic testing when hereditary syndromes are suspected.
Nursing Responsibilities
Nursing responsibilities focus on medicine reconciliation, preservative-ready containers, spell-symptom documentation, refrigerated timed collection, volume reporting, and urgent communication when symptoms or critical results appear.
Before the TestDocumentation
Documentation should prove preservative use, exact start/stop times, complete collection, total volume, medicine holds, and symptom correlation.
“24-hour urinary catecholamines: 50% acetic acid preservative (25 mL) verified in container before start. Collection 07:15 day 1 to 07:15 day 2; first void discarded after empty bladder; all subsequent voids included; container refrigerated. Total volume 1,840 mL documented. Patient reported spell with BP 192/108, palpitations, and diaphoresis at 14:30 during collection. MAOI held 10 days per prescriber; no caffeine x 48 h. Specimen transported on ice per protocol. Pending fractionated results; endocrine notified of collection quality.”
- Preservative type and confirmation it was added before first void
- Exact 24-hour start and stop times and total volume in milliliters
- Medicine holds, sympathomimetics, and infusion stops per protocol
- Spell symptoms, blood pressure, and heart rate during collection window
- Refrigeration method and any missed voids or collection deviations
- Result notification, critical-value policy follow-through, and prescriber read-back
Patient and Family Education
Use plain language while emphasizing why every void and the cold container matter.
Urinary Catecholamines NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Urinary Catecholamines safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: 24-hour urinary catecholamines — fractionated (epinephrine, norepinephrine, dopamine)
- Indication: Episodic hypertension with palpitations and diaphoresis; metanephrines indeterminate
- Timing: Collection started yesterday; patient unsure whether preservative was in container at start
- Related orders: Fractionated plasma metanephrines (prior); abdominal CT pending endocrine review if biochemistry confirms
- Result: Urinary catecholamines pending; prior metanephrines mildly elevated above reference
- Trend / prior value: Overnight BP 148/92–176/104 during collection; HR 88–118/min with reported sweating spells
- Pending tests: Outpatient endocrine follow-up; alpha-blockade not yet ordered
- Vital signs: HR 104/min, BP 168/98 mmHg, temp 37.0°C, SpO₂ 98% on room air
- Symptoms: Intermittent pounding heartbeat, diaphoresis, mild tremor — no chest pain today
- Focused assessment: Alert, anxious during spell; lungs clear; no focal neurologic deficit
- Preparation notes: Patient drank two cups of coffee morning of collection start; MAOI stopped 5 days ago (10-day hold requested)
- Collection events: Preservative status uncertain; all voids reportedly included; container kept in home refrigerator
- Teaching gaps / safety concerns: Uncertain preservative; caffeine exposure; MAOI hold shorter than laboratory guidance; active hypertensive spells during collection
Answer key & rationale
Frequently Asked Questions
FAQ
Is urinary catecholamine testing the first step for pheochromocytoma?
No. the reporting laboratory states fractionated plasma or 24-hour urine metanephrines are the recommended first-line tests. Urinary catecholamines are auxiliary when metanephrine results leave diagnostic uncertainty.
Why must preservative be added before the first void?
Mayo collection instructions require acid or approved preservative at the start to maintain pH approximately 2–4 and protect catecholamines during the 24-hour period. Preservative added late may invalidate the specimen.
Should the patient collect urine during a spell?
Mayo ordering guidance the assay is of greatest value when the specimen is collected during a hypertensive episode or symptomatic spell. Document when symptoms occurred relative to the collection window.
Which medicines interfere with urinary catecholamines?
Mayo patient preparation lists drugs that release or block catecholamine metabolism — often requiring at least one week off when medically feasible — and catecholamine infusions for at least 12 hours. Provide a complete medicine list and follow prescriber hold instructions; contact the laboratory if withdrawal is not possible.
What reference intervals should nurses use?
Use the reporting laboratory’s age- and sex-matched intervals. Mayo publishes fraction-specific pediatric and adult ranges — do not apply universal numbers across institutions or analyzers.
Can caffeine or nicotine affect results?
Yes. Mayo cautions note short-term increases from caffeine and nicotine among environmental factors that raise endogenous catecholamines. Follow laboratory avoidance instructions before and during collection.
When should nurses escalate despite pending urine results?
Escalate according to facility policy for hypertensive emergency features, hemodynamic instability, chest pain, neurologic symptoms, or critical laboratory notifications — do not delay urgent care waiting for urine catecholamines alone.
References
References
-
Mayo Clinic Laboratories. Catecholamine Fractionation, Free, 24 Hour, Urine (CATU). Test Catalog.https://www.mayocliniclabs.com/test-catalog/overview/9276
-
Mayo Clinic Laboratories. Metanephrines with 3-Methoxytyramine, 24 Hour, Urine (META3). Test Catalog.https://www.mayocliniclabs.com/test-catalog/overview/65158
-
Memorial Sloan Kettering Cancer Center. 24-Hour Urine Collection Instructions for Metanephrines and Catecholamines Test.https://www.mskcc.org/pdf/cancer-care/patient-education/24-hour-urine-collection-metanephrines-catecholamines-test
-
Moyer TP; Jiang NS; Tyce GM; Sheps SG. Analysis for urinary catecholamines by liquid chromatography with amperometric detection. Clin Chem. 1979.https://pubmed.ncbi.nlm.nih.gov/76298/
-
National Institute of Neurological Disorders and Stroke. Pheochromocytoma and Paraganglioma Information Page. NIH.https://www.ninds.nih.gov/health-information/disorders/pheochromocytoma-and-paraganglioma
-
National Cancer Institute. Neuroblastoma Treatment (PDQ) — Health Professional Version. NIH.https://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq
-
U.S. National Library of Medicine. Catecholamine Tests. MedlinePlus Lab Tests.https://medlineplus.gov/lab-tests/catecholamine-tests/
-
Lenders JWM; et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014.https://pubmed.ncbi.nlm.nih.gov/24893193/
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Urinary Catecholamines.
Policies: Medical Review Process · Editorial Policy · Correction Policy